RAD51C and cancer: Full-length RAD51C knock-out is lethal in normal and cancer cells with some exceptions3,8,9, and functional RAD51C variant testing so far relied on knockdown of the protein or variant overexpression in cells that have overcome RAD51C essentiality, which may have secondary effects.